Madina I. Baipakova

Madina I. Baipakova

Auto-generated profile, based on publicly available information

Madina I. Baipakova


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2025 in Experimental and Сlinical Urology
Verified
Journal Article
Open access
TFthe Department of Surgical Diseases and Urology of the Omsk State Medical University of the Ministry of Health of the Russian Federation
the Department of Surgical Diseases and Urology of the Omsk State Medical University of the Ministry of Health of the Russian Federation
ATA.YU. Tsukanov
A.YU. Tsukanov
MBM.I. Baypakova
M.I. Baypakova
RORussia City Clinical Perinatal Center; Omsk
Russia City Clinical Perinatal Center; Omsk
VDV.P. Dorofeeva
V.P. Dorofeeva
ISI.O. Snitko
I.O. Snitko
Introduction. Radiation injury of the bladder is a complication after therapeutic irradiation of the pelvic organs. The strategy of pharmacotherapy of such complications is currently unclear due to the small number of studies and unclear pathogenesis. Purpose of the study – to study the effectiveness of the use of bovine bladder polypeptides in modeling radiation injury of the bladder in rats. Materials and methods. An animal model of radiation cystitis was formed by a single irradiation at a dose of 20 Gy with determination of the isocenter on a 3D model. The study used 55 female Wistar rats, which were divided into 5 groups: group 1 – intact, without exposure; group 2 – negative control (irradiation without therapy); group 3 – therapy with Vezusten, starting from the 10th day after irradiation, intramuscularly daily for 10 days, at a dose of 0.056 mg/kg, in a volume of 0.1 ml; Group 4 – administration of Vezusten to intact animals, intramuscularly daily for 10 days, at a dose of 0.056 mg/kg, in a volume of 0.1 ml; Group 5 – «standard therapy» was administered, instillation of a combination of hydrocor- tisone+heparin+lidocaine for 10 days, starting from the 10th day after irradiation. The animals were withdrawn on the 40th day after irradiation. Results. In the achieved model of radiation cystitis, in the group receiving the peptide drug Vezusten, much less damage to the bladder wall was noted (preservation of epithelial stratification, folding, plethora of the submucosal layer), as well as better tolerance of irradiation and the post-radiation period (less pronounced alopecia, minimal skin changes in the places of animal fixation, physiological behavior of the animal). Conclusion. In the achieved experimental model of radiation cystitis in rats, the introduction of regulatory polypeptides of the urinary bladder of cattle (the drug Vezusten) significantly reduced both the clinical manifestations of radiation injury and normalized the morphological picture. Probably, the reparative effect of Vezusten is realized, among other things, due to the normalization of the expression of the paracrine peptide factor TGF-β1, compared to animals without therapy.

25 March 2025 in Experimental and Сlinical Urology
Verified
Journal Article
Open access
ATA.YU. Tsukanov
A.YU. Tsukanov
ISI.V. Savelyeva
I.V. Savelyeva
EKE.V. Kulchavenya
E.V. Kulchavenya
KIKh.S. Ibishev
Kh.S. Ibishev
MFM.A. Firsov
M.A. Firsov
LTL.S. Treyvish
L.S. Treyvish
Introduction. Asymptomatic bacteriuria (AB) is a form of urinary tract infection (UTI) that occurs without any symptoms. Its incidence fluctuates around 6%. The generally accepted paradigm suggests the need to treat AB, but this statement is mainly based on research data from the 1950-70 years. Objective. To study the effect of antimicrobial drugs in the treatment of AB in pregnant women on obstetric and perinatal outcomes and urological complications. Materials and methods. A multicenter retrospective study was conducted involving 182 pregnant women aged 18 to 45 years with established AB. During the study, the pregnant women were divided into 4 groups with different criteria; Group 1 (n=44) received treatment with protected penicillins; Group 2 (n=47) received treatment with fosfomycin; Group 3 (n=40) the drug of choice was cephalosporin; Group 4 (n=51) patients with normal pregnancy. Results. No significant differences were found in mean age, obstetric outcomes, and urological complications. Preterm birth was more common in Group 1 compared to Group 2, preeclampsia was also more common in Group 1, but Group 2 tended to have an increased incidence of the complication. Low fetal weight was more common in Group 1 and Group 3, but fetal hypoxia was more common in Group 2, and it was not possible to associate this complication with antibiotic use. Conclusion. Further studies are needed to assess both the association of AB in pregnant women with gestational pyelonephritis and to determine the benefits of prescribing antimicrobials for this type of UTI.

1 January 2025 in Bulletin of Medical Science
Verified
Journal Article
Open access
ATAnton Yu. Tsukanov
Anton Yu. Tsukanov
MBMadina I. Baipakova
Madina I. Baipakova
OCOmsk City Clinical Perinatal Center
Omsk City Clinical Perinatal Center
EMEvgeny V. Matveev
Evgeny V. Matveev
MSMarina A. Stepkina
Marina A. Stepkina
ANAlexandra B. Neymark
Alexandra B. Neymark
The presented review of the literature is devoted to the analysis of methods of treatment and prevention of radiation cystitis. Radiation cystitis (RC) is a type of painful bladder syndrome (PBS), which dramatically affects the quality of life of patients, reduces social adaptation, and leads to disability. In addition to the impact on the physical component of the patient, there is also psycho-emotional stress, which leads to suicidal moments, according to some data (11%). Our understanding of the etiology and pathophysiology is growing, altered permeability of the damaged urothelium, sensitized nerves on the bladder wall, and chronic or intermittent sensory pain with imprecise location, as well as pathological angiogenesis, fibrosis are obstacles to better diagnosis and treatment. The aim of this study was to summarize all the information on RC research, thus contributing to the progress of RC in aspects of diagnosis, treatment, prevention, and prognosis.